Viewing Study NCT00215995


Ignite Creation Date: 2025-12-24 @ 1:58 PM
Ignite Modification Date: 2025-12-30 @ 11:33 AM
Study NCT ID: NCT00215995
Status: COMPLETED
Last Update Posted: 2012-01-13
First Post: 2005-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module